Evidence map›Paper›PMID 26178245›Full record

ArticleTransgenic research2015

Expression of the β-1,3-glucanase gene bgn13.1 from Trichoderma harzianum in strawberry increases tolerance to crown rot diseases but interferes with plant growth.

José A Mercado, Marta Barceló, Clara Pliego, Manuel Rey, José L Caballero, Juan Muñoz-Blanco, David Ruano-Rosa, Carlos López-Herrera, Berta de Los Santos, Fernando Romero-Muñoz and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Strain improvement ofFrontiers in microbiology · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. Olive (Genes · 2021
    Review
  9. Article
  10. Article
  11. Review
  12. Trichoderma for climate resilient agriculture.World journal of microbiology & biotechnology · 2017
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

José A MercadoDepartamento de Biología Vegetal, Instituto de Hortofruticultura Subtropical y Mediterránea "La Mayora", IHSM-UMA-CSIC, Universidad de Málaga, 29071, Málaga, Spain. mercado@uma.es.
Marta BarcelóIFAPA, Centro de Churriana, 29140, Málaga, Spain.
Clara PliegoIFAPA, Centro de Churriana, 29140, Málaga, Spain.
Manuel ReyNewbiotechnic S.A., 41110, Seville, Spain.
José L CaballeroDepartamento de Bioquímica y Biología Molecular, Universidad de Córdoba, Córdoba, Spain.
Juan Muñoz-BlancoDepartamento de Bioquímica y Biología Molecular, Universidad de Córdoba, Córdoba, Spain.
David Ruano-RosaInstituto de Agricultura Sostenible, CSIC, 14080, Córdoba, Spain.
Carlos López-HerreraInstituto de Agricultura Sostenible, CSIC, 14080, Córdoba, Spain.
Berta de Los SantosIFAPA, Centro Las Torres-Tomejil, 41200, Seville, Spain.
Fernando Romero-MuñozIFAPA, Centro Las Torres-Tomejil, 41200, Seville, Spain.
Fernando Pliego-AlfaroInstituto de Hortofruticultura Subtropical y Mediterránea "La Mayora", IHSM-UMA-CSIC, Universidad de Málaga, 29071, Málaga, Spain.
Andalusian Institute of Agricultural and Fisheries Research and Training · ESInstituto de Agricultura Sostenible · ESUniversity of Córdoba · ESInstituto de Hortofruticultura Subtropical y Mediterránea "La Mayora" · ESInternational Centre for Advanced Mediterranean Agronomic Studies · ESNewbiotechnic (Spain) · ESUniversidad de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expression of antifungal genes from Trichoderma harzianum, mainly chitinases, has been used to confer plant resistance to fungal diseases. However, the biotechnological potential of glucanase genes from Trichoderma has been scarcely assessed. In this research, transgenic strawberry plants expressing the β-1,3-glucanase gene bgn13.1 from T. harzianum, under the control of the CaMV35S promoter, have been generated. After acclimatization, five out of 12 independent lines analysed showed a stunted phenotype when growing in the greenhouse. Moreover, most of the lines displayed a reduced yield due to both a reduction in the number of fruit per plant and a lower fruit size. Several transgenic lines showing higher glucanase activity in leaves than control plants were selected for pathogenicity tests. When inoculated with Colletotrichum acutatum, one of the most important strawberry pathogens, transgenic lines showed lower anthracnose symptoms in leaf and crown than control. In the three lines selected, the percentage of plants showing anthracnose symptoms in crown decreased from 61 % to a mean value of 16.5 %, in control and transgenic lines, respectively. Some transgenic lines also showed an enhanced resistance to Rosellinia necatrix, a soil-borne pathogen causing root and crown rot in strawberry. These results indicate that bgn13.1 from T. harzianum can be used to increase strawberry tolerance to crown rot diseases, although its constitutive expression affects plant growth and fruit yield. Alternative strategies such as the use of tissue specific promoters might avoid the negative effects of bgn13.1 expression in plant performance.

Indexed as

Disease ResistanceFragariaFruitGene Expression Regulation, EnzymologicGene Expression Regulation, PlantGlucan 1,3-beta-GlucosidasePlant DiseasesPlant LeavesPlant RootsPlants, Genetically ModifiedTrichodermaGlucan 1,3-beta-GlucosidaseAnthracnoseColletotrichum acutatumFragaria × ananassaFungal resistanceRosellinia necatrixTransgenic plantsWhite root rot

Identifiers

PMID26178245
OpenAlexW961448353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.